Bile Duct Cancer (Cholangiocarcinoma) | Johns Hopkins Medicine
Full article: Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy
Conquer: the journey informed - Cholangiocarcinoma: Your Patient Journey
Surface Markers of Cancer Stem Cells in Cholangiocarcinoma (CCA). | Download Scientific Diagram
Predictive value of multiple serum tumor markers | CMAR
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System
Molecular heterogeneity in intrahepatic cholangiocarcinoma
The pros and cons of the PCC staging system to guide surgical resectability and prognosis
Tumor markers | PPT
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table
Epigenome Remodeling in Cholangiocarcinoma: Trends in Cancer
Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type